Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Redefining risk in acute coronary syndromes using molecular medicine.

Journal of the American College of Cardiology - 23 Jan 2007

Anwaruddin Saif, Askari Arman T, Topol Eric J

Abstract excerpt

Acute coronary syndromes represent a complex phenotype involving the interplay of many elements. The risk of developing an acute coronary syndrome and related complications has been defined by variables such as age, diabetes, smoking history, serum creatine phosphokinase, or electrocardiographic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angina, Unstable
Share to C-Reactive Protein
Share to CD40 Ligand

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Biology

Share to Myocardial Infarction

Share to P-Selectin

Share to Sensitivity and Specificity

Share to Troponin T

Source

Identifiers

PMID: 17239708
DOI: 10.1016/j.jacc.2006.08.051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17239708-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Redefining risk in acute coronary syndromes using molecular medicine.PMID 17239708Read ↗

Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.Semantic proximity Read ↗

Molecular signatures of cardiovascular disease risk: potential for test development and clinical application.Semantic proximity Read ↗

Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.Semantic proximity Read ↗

Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.Semantic proximity Read ↗

Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.Semantic proximity Read ↗

Genome-wide association study of cardiac troponin I in the general population.Semantic proximity Read ↗

Using human genetics to understand the causes and consequences of circulating cardiac troponin I in the general populationSemantic proximity Read ↗

Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance.Semantic proximity Read ↗

Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection FractionSemantic proximity Read ↗

Genetics of myocardial infarction.Semantic proximity Read ↗

Risk stratification and management of sudden cardiac death: a new paradigm.Semantic proximity Read ↗

Prospects for personalized cardiovascular medicine: the impact of genomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.